Targeting the epitope spreader Pep19 by naive human CD45RA+ regulatory T cells dictates a distinct suppressive T cell fate in a novel form of immunotherapy
- Targeting the epitope spreader Pep19 by naive human CD45RA+ regulatory T cells dictates a distinct suppressive T cell fate in a novel form of immunotherapy
- 이정애; 김현주; 차길선; 주지영; 이주연; 김성조; 박수연; 최점일
- Adoptive transfer; Autoimmune diseases; Heat-shock proteins; Immune tolerance; Regulatory T-lymphocytes; Rheumatoid arthritis
- Issue Date
- Journal of Periodontal and Implant Science
- VOL 47, NO 5-311
- Purpose: Beyond the limited scope of non-specific polyclonal regulatory T cell (Treg)-based
immunotherapy, which depends largely on serendipity, the present study explored a target
Treg subset appropriate for the delivery of a novel epitope spreader Pep19 antigen as part of a sophisticated form of immunotherapy with defined antigen specificity that induces immune
Methods: Human polyclonal CD4+CD25+CD127lo− Tregs (127-Tregs) and naï ve CD4+CD25+
CD45RA+ Tregs (45RA-Tregs) were isolated and were stimulated with targetpeptide 19 (Pep19)-pulsed dendritic cells in a tolerogenic milieu followed by ex vivo expansion. Low-dose interleukin-2 (IL-2) and rapamycin were added to selectively exclude the outgrowth of contaminating effector T cells (Teffs). The following parameters were investigated in the expanded antigen-specific Tregs: the distinct expression of the immunosuppressive Treg marker Foxp3, epigenetic stability (demethylation in the Treg-specific demethylated region), the suppression of Teffs, expression of the homing receptors CD62L/CCR7, and CD95Lmediated apoptosis. The expanded Tregs were adoptively transferred into an NOD/scid/IL-2Rγ− /− mouse model of collagen-induced arthritis.
Results: Epitope-spreader Pep19 targeting by 45RA-Tregs led to an outstanding in vitro suppressive T cell fate characterized by robust ex vivo expansion, the salient expression of Foxp3, high epigenetic stability, enhanced T cell suppression, modest expression of CD62L/CCR7, and higher resistance to CD95L-mediated apoptosis. After adoptive transfer, the distinct fate of these T cells demonstrated a potent in vivo immunotherapeutic capability, as indicated by the complete elimination of footpad swelling, prolonged survival, minimal histopathological changes, and preferential localization of CD4+CD25+ Tregs at the articular joints in a mechanistic and orchestrated way.
Conclusions: We propose human n
- Appears in Collections:
- KIST Publication > Article
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.